Glucose-6-phosphate dehydrogenase (G6PD) has an essential role in the defense against cellular oxidative injury. In neonates, the most common manifestation of G6PD deficiency is jaundice and hemolysis due to factors causing oxidative stress. Less known are the ocular associations described with G6PD deficiency, including cataracts. Oxidative injury is involved in the pathogenesis of almost all forms of cataracts, causing the lens proteins to undergo modifications, denaturation and form insoluble aggregates resulting in cataracts. Although cataracts in adult males have been reported in several studies, there are few reports of cataracts in infants with G6PD deficiency. We describe a preterm male neonate with G6PD deficiency who developed bilateral cataracts following an episode of neonatal sepsis and severe hemolysis necessitating an exchange blood transfusion.
INTRODUCTION
Glucose-6-phosphate dehydrogenase (G6PD) deficiency, an X-linked disorder, is the most common enzyme deficit in humans, affecting 400 million people worldwide. The enzyme deficiency is more prevalent in Central Africa, Middle East, South East Asia and Southern Europe, including Greece and Italy. 1 However, with the ease of travel and immigration in today's world, diseases are no longer confined to strict geographical areas and G6PD deficiency is being reported from areas where it is uncommon. 1 Although the most common manifestations of G6PD deficiency are jaundice and acute hemolytic anemia, lesser known are the ocular associations with G6PD deficiency including cataracts. 2 Cataracts in adult males (o50 years) with G6PD deficiency have been reported in several studies. [3] [4] [5] However, very few studies have described cataracts in infants with G6PD deficiency. 6 We describe a preterm male neonate with G6PD deficiency who developed bilateral cataracts after an episode of neonatal sepsis and severe hemolysis. To our knowledge, this is the first report of cataracts with G6PD deficiency in the neonatal period.
CASE
A 1320 g male infant, the first of diamniotic dichorionic twins, was born at 28 þ 3 weeks gestation to a 37-year-old mother of Greek origin. The mother had regular antenatal care with normal ultrasounds at 9 and 18 weeks. Serologic tests for syphilis, hepatitis B and HIV were negative and she was immune to both rubella and varicella. There was no history of gestational diabetes, hypertension, fever, rash or other significant illness during the pregnancy. Other than vitamins, she was not recieving any medications. The parents did not report contact with cats and were non-consanguineous. There was no family history of significant disease.
Delivery was by C-section because of spontaneous onset of labor and placenta previa. Physical examination was normal. Red reflex was present bilaterally. The infant received surfactant for respiratory distress syndrome after birth and phototherapy on day 3 and 4 of life for mild hyperbilirubinemia. A patent ductus arteriosus was treated with ibuprofen on day 4 and 5 of life. The infant was relatively stable until day 7 of life when he acutely developed lethargy, pallor and jaundice accompanied with persistent apnea and bradycardia events. He was treated with endotracheal intubation and assisted ventilation. Following evaluation for sepsis, the infant was started on antibiotics. Over a period of 12 h the hematocrit decreased from 36 to 26% with an elevated reticulocyte count and the bilirubin increased from 6.8 to 13.8 mg dl À 1 . An exchange blood transfusion was performed. Blood culture was positive for Staphylococcus aureus. The infant was found to be G6PD-deficient with levels of 0.5 units per g of hemoglobin (normal range 4.6 to 13.5 units, Trinity Biotech, Bray, Ireland). Following antibiotic therapy for 14 days, the infant did well. At 4 weeks of life, while undergoing screening for retinopathy of prematurity, the infant was found to have lens vacuoles bilaterally. Follow-up examination over the next 5 weeks showed progression to dense, bilateral cataracts with multilayered vacuoles in the posterior cortex of each crystalline lens. A metabolic screen including plasma amino acids, urinary organic acids, plasma acyl-carnitine and carnitine profile was normal. Urine was negative for reducing substances, and urinary sugar chromatography, while the infant was on breast milk, was normal. The infant was also evaluated by the medical genetics team who, given the infant's history and examination, did not think any genetic workup was warranted. As there was progression of the cataracts, surgery was performed at 3 months of age (Figure 1 ). The infant is now 2 years old without any further episode of hemolysis and is fed regular milk formula and diet appropriate for his age.
DISCUSSION
There have been sporadic reports of congenital and childhood cataracts associated with G6PD deficiency. Assaf et al. 6 have reported a series of 12 patients with G6PD deficiency with bilateral cataracts without an evidence of any genetic or metabolic disorder. The youngest patient in their series was a 3-month-old infant. Zeng et al. have described 57 patients who along with G6PD deficiency had ocular findings including cataracts. One patient in their series had congenital cataracts, although the exact age at which the patient presented is not reported. 7 Others have reported older infants with bilateral cataracts and G6PD deficiency, 8, 9 including one who had received several blood transfusions because of hemolysis. 10 There are, however, several reports of cataracts associated with G6PD deficiency in males o50 years of age. These include reports from Italy, South Asia, Sardinia and Turkey. [3] [4] [5] The few reports that have not demonstrated this association have been criticized for having too old a population (450 years), where cataractogenic factors other than G6PD may come into play masking the effect of G6PD deficiency. In addition, these studies have not separated the females from males in their population, as males have a more severe deficiency of the enzyme. 4 Mechanisms resulting in cataracts in G6PD deficiency have been elucidated by several investigators. The major function of G6PD is to protect cells against oxidative damage by replenishing cellular reduced glutathione (GSH), an extremely important antioxidant. 2 The avascular lens maintains its transparency through a discrete organization of its cells and proteins, prominent among which are the crystalline proteins. 11 As the crystalline proteins are especially susceptible to oxidative injury, the lens maintains high levels of GSH. 12 Some investigators have suggested that the major source of GSH in the lens is from the pentose phosphate pathway where G6PD has a critical role. 2, 12 Oxidative injury is thought to be involved in almost every form of cataracts and in cataractous lens, levels of GSH are decreased. 2, 11 Oxidative injury to the crystalline proteins results in the formation of high molecular weight insoluble protein aggregates, leading to cataract formation. 11, 13 Septicemia can cause severe oxidative stress in neonates. 1, 14 In our patient, S. aureus infection resulted in severe hemolysis requiring an exchange blood transfusion, which in itself causes oxidative stress. In addition, preterm neonates have reduced levels of antioxidant factors and enzymes.
14 Although the youngest previously reported infant patient with G6PD deficiency and cataracts was 3 months old, animal data indicate that severe oxidative stress can result in cataracts within days. Preweaning mice and rats treated with buthionine sulfoximine, an inhibitor of glutathione synthesis, develop bilateral cataracts within 48 to 72 h. 15, 16 Importantly, in the developing preterm lens the aqueousblood barrier may not have been established adequately, making the preterm lens especially vulnerable to oxidative injury. 16 The unremarkable family and antenatal history, physical examination or laboratory results did not suggest a genetic, metabolic or infectious cause of cataracts in our patient. Most genetic cataracts are autosomal dominant and may be associated with other ocular findings and dysmorphic features, the absence of which makes this an unlikely cause for cataracts in our patient. Parents were nonconsanguineous, making autosomal recessive disorders also improbable. An extensive metabolic workup, including workup for galactosemia, was negative. Other than cataracts, the infant did not have any other evidence of congenital infection such as conjugated hyperbilirubinemia, thrombocytopenia, organomegaly or growth retardation. Furthermore, all maternal serologic tests were negative. Given the presence of bilateral red reflex at birth, negative metabolic investigations, absence of dysmorphic features and stigmata of congenital infections and the increased susceptibility of the preterm lens to oxidative injury, we conclude that the most plausible cause of bilateral cataracts in this infant was severe oxidative stress in the presence of G6PD deficiency. Preterm neonates with acute hemolysis due to G6PD deficiency may be at risk for developing cataracts. The cataract is visible as numerous dense vacuoles, which overlap at multiple layers within the crystalline lens and are located peripherally as well as centrally, and which obscure the red reflex normally seen in the dilated pupil through the operating microscope.
